Ekaterina Chelysheva

Author

National Medical Research Center for Hematology

Also Known As

E Yu Chelysheva, E. Chelysheva, E. Y. Chelysheva, E. Yu. Chelysheva, E.Y. Chelysheva, Ekaterina CHELYSHEVA, Ekaterina Chelysheva, Ekaterina Yu. Chelysheva

Publications

190

Citations

H-Index

Concepts

All Affiliations

National Medical Research Center for Hematology Centre Hospitalier de Versailles Institute of Haematology and Blood Transfusion Hospital Clínic de Barcelona Universidade Federal do Rio de Janeiro

About

Ekaterina Chelysheva is an author at National Medical Research Center for Hematology specializing in oncology, medicine, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	30
2	Engineering	1	1	16
3	Pathology	1	1	16
4	Pharmacology	1	1	14
5	Genetic Epidemiology	1	1	16

Ekaterina Chelysheva

Publications

116

Citations

H-Index

Page 1

	Year	Citations
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022 Jon Salmanton‐García, Francesco Marchesi, Francesca Farina, EClinicalMedicine	2024	29
PF-114: A 4th Generation Tyrosine Kinase-Inhibitor for Chronic Phase Chronic Myeloid Leukaemia Including BCRABL1T315I Anna Turkina, Olga Vinogradova, Elza Lomaia, Blood	2019	18
Whole-exome sequencing reveals potential molecular predictors of relapse after discontinuation of the targeted therapy in chronic myeloid leukemia patients Svetlana Smirnikhina, Ekaterina Chelysheva, Elmira P. Adilgereeva, Leukemia & lymphoma/Leukemia and lymphoma Hematological MalignancyChronic Myeloid LeukemiaEngineeringHigh SensitivityMedicine	2016	16
Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database Elisabetta Abruzzese, Anna Turkina, Jane F. Apperley, Blood	2019	15
Withdrawal Syndrome After Tyrosine Kinase Inhibitor Discontinuation in Patients With Chronic Myeloid Leukemia in the Russian Prospective Study RU-SKI Ekaterina Chelysheva, Oleg Shukhov, Anastasiya Bykova, Clinical Lymphoma Myeloma & Leukemia Hematological MalignancyWithdrawal SyndromeChronic Myeloid LeukemiaMedicineMixed-phenotype Acute Leukemia	2020	14
Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings Giuseppe Rossi, Jon Salmanton‐García, Chiara Cattaneo, International Journal of Infectious Diseases	2023	14
The ability of multipotent mesenchymal stromal cells from the bone marrow of patients with leukemia to maintain normal hematopoietic progenitor cells Tamara Sorokina, Irina N. Shipounova, Alexey Bigildeev, European Journal Of Haematology	2015	10

Page 1